IV epoprostenol for systemic sclerosis.
Klings
E S
ES
Farber
H W
HW
D011464:Epoprostenol / Q000008:administration & dosage*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D007275:Injections, Intravenous; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011669:Pulmonary Wedge Pressure / Q000187:drug effects; D012595:Scleroderma, Systemic / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D014655:Vascular Resistance / Q000187:drug effects
D010975:Platelet Aggregation Inhibitors; D011464:Epoprostenol